HAMBURG, Germany and OXFORD, England, September 28 /PRNewswire-FirstCall/ -- Evotec AG today announced it has received a Certificate of GMP Compliance from the Medicines and Healthcare Products Regulatory Agency (MHRA). This replaces the old statement of cGMP compliance previously issued.
Dr Mario Polywka, Chief Operating Officer at Evotec, said: "It is gratifying to receive validation of our high quality process development, manufacturing, analytical and quality assurance capabilities through this certification. We are proud to be one of the first companies to receive the new MHRA certificate in place of the old statement of compliance. This certificate means we continue to provide our customers with the best possible facilities and processes to manufacture their drug compounds. I would like to thank our fantastic Quality Department for maintaining such high standards."
Contact:
Evotec AG, Anne Hennecke, Investor Relations, Schnackenburgallee 114, 22525 Hamburg, Germany, Phone: +49-(0)40-56081-286, Fax: +49-(0)40-56081-333, E-mail: investor.relations@evotec.com
Evotec AGCONTACT: Contact: Evotec AG, Anne Hennecke, Investor Relations,Schnackenburgallee 114, 22525 Hamburg, Germany, Phone: +49-(0)40-56081-286,Fax: +49-(0)40-56081-333, E-mail: investor.relations@evotec.com
